Acurx Pharmaceuticals Inc (ACXP)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
May 10, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Cash from Operations (TTM): -9.801M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.801M |
| September 30, 2023 | -7.099M |
| June 30, 2023 | -7.185M |
| March 31, 2023 | -7.599M |
| December 31, 2022 | -7.542M |
| September 30, 2022 | -7.547M |
| June 30, 2022 | -8.003M |
| Date | Value |
|---|---|
| March 31, 2022 | -6.343M |
| December 31, 2021 | -5.014M |
| September 30, 2021 | -4.473M |
| June 30, 2021 | -2.596M |
| March 31, 2021 | -2.999M |
| December 31, 2020 | -3.352M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.801M
Minimum
Dec 2023
-2.596M
Maximum
Jun 2021
-6.119M
Average
-7.099M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -102.00M |
| Seelos Therapeutics Inc | -23.91M |
| PetVivo Holdings Inc | -7.190M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |